This inventor holds 1 USPTO granted patent. Top assignee: Emory University. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Dawn E Post - Innovator in Hypoxia-Targeted Therapeutics
Introduction
Dawn E Post is a prominent inventor based in Duluth, GA (US). She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic strategies targeting hypoxic cells and tissues. Her innovative work has the potential to advance treatments for various medical conditions.
Latest Patents
Dawn E Post holds a patent for "Viruses targeted to hypoxic cells and tissues." This invention relates to compositions comprising a novel recombinant virus that selectively replicates in cells or tissues that are hypoxic or have an activated HIF pathway. The compositions include a recombinant virus genetically engineered to have a hypoxia/HIF-responsive element, operably linked to a promoter, which is in turn linked to nucleic acids encoding peptides that regulate or modulate the virus's replication and/or encode therapeutic molecules. The invention also encompasses constructs useful for screening agents that interact with proteins or genes in the hypoxia-inducible pathway and animal models for monitoring hypoxic conditions non-invasively.
Career Highlights
Dawn E Post is affiliated with Emory University, where she continues her research and development efforts. Her work has garnered attention for its innovative approach to addressing challenges in hypoxia-related therapies.
Collaborations
Some of her notable coworkers include Ainsley C Nicholson and Erwin Van Meir, who contribute to her research endeavors and collaborative projects.
Conclusion
Dawn E Post is a trailblazer in the field of hypoxia-targeted therapeutics, with her patent showcasing her innovative contributions to biotechnology. Her work at Emory University and collaborations with esteemed colleagues further highlight her impact in this vital area of research.